DƯỢC LÍ Goodman & Gilman's The Pharmacological Basis of Therapeutics 12th, 2010

118
SECTION I
GENERAL PRINCIPLES
Hasegawa M, Kusuhara H, Adachi M, et al. Multidrug
resistance-associated protein 4 is involved in the urinary
excretion of hydrochlorothiazide and furosemide. J Am Soc
Nephrol, 2007, 18:37–45.
Hediger MA (ed.). In, Special Issue: The ABCs of solute carriers:
Physiological, pathological and therapeutic implications of
human membrane transport proteins. Pflügers Arch, 2004,
447:465–468.
Hediger MA, Coady MJ, Ikeda TS, Wright EM. Expression
cloning and cDNA sequencing of the Na + /glucose cotransporter.
Nature, 1987, 330:379–381.
Hirano M, Maeda K, Shitara Y, Sugiyama Y. Contribution of
OATP2 (OATP1B1) and OATP8 (OATP1B3) to the hepatic
uptake of pitavastatin in humans. J Pharmacol Exp Ther, 2004,
311:139–146.
Ho ES, Lin DC, Mendel DB, Cihlar T. Cytotoxicity of antiviral
nucleotides adefovir and cidofovir is induced by the expression
of human renal organic anion transporter 1. J Am Soc Nephrol,
2000, 11:383–393.
Hog S, Greenwood JR, Madsen KB, et al. Structure-activity
relationships of selective GABA uptake inhibitors. Curr Top
Med Chem, 2006, 6:1861–1882.
Hollenstein K, Dawson R, Locher K. Strucutre and mechanism
of ABC transporter proteins. Curr Opin Structural Biol, 2007,
17:412–418.
Horio M, Pastan I, Gottesman MM, Handler JS. Transepithelial
transport of vinblastine by kidney-derived cell lines:
Application of a new kinetic model to estimate in situ K m
of
the pump. Biochem Biophys Acta, 1990, 1027:116–122.
Imai S, Kikuchi R, Kusuhara H, et al. Analysis of DNA
methylation and histone modification profiles of liver-specific
transporters. Mol Pharmacol, 2009, 75:568–576.
Imaoka T, Kusuhara H, Adachi M, et al. Functional involvement
of multidrug resistance-associated protein 4 (MRP4/ABCC4)
in the renal elimination of the antiviral drugs adefovir and
tenofovir. Mol Pharmacol, 2006, 71:619–627.
Ishiguro N, Maeda K, Kishimoto W, et al. Predominant
contribution of OATP1B3 to the hepatic uptake of telmisartan,
an angiotensin II receptor antagonist, in humans. Drug Metab
Dispos, 2006, 34:1109–1115.
Ishiguro, N, Maeda, K, Saito, A, et al., Establishment of a set of
double transfectants coexpressing organic anion transporting
polypeptide 1B3 and hepatic efflux transporters for the
characterization of the hepatobiliary transport of telmisartan
acylglucuronide. Drug Metab Dispos, 2008, 36:796–805.
Ishikawa T, Muller M, Klunemann C, et al. ATP-dependent
primary active transport of cysteinyl leukotrienes across liver
canalicular membrane: Role of the ATP-dependent transport
system for glutathione S-conjugates. J Biol Chem, 1990,
265:19279–19286.
Ito K, Suzuki H. Hirohashi T, et al. Molecular cloning of
canalicular multispecific organic anion transporter defective
in EHBR. Am J Physiol, 1997, 272:G16–G22.
Jonker JW, Buitelaar M, Wagenaar E, et al. The breast cancer
resistance protein protects against a major chlorophyll-derived
dietary phototoxin and protoporphyria. Proc Natl Acad Sci
USA, 2002, 99:15649–15654.
Juliano RL, Ling V. A surface glycoprotein modulating drug
permeability in Chinese hamster ovary cell mutants. Biochem
Biophys Acta, 1976, 455:152–162.
Jutabha P, Kanai Y, Hosoyamada M, et al. Identification of a
novel voltage-driven organic anion transporter present at apical
membrane of renal proximal tubule. J Biol Chem, 2003,
278:27930–27938.
Kanner B. It’s not all in the family. Nature, 2008, 454:593–594.
Karpowich N, Wang D. Symmetric transporters for asymmetric
transport. Science, 2008, 321:781–782.
Kekuda R, Prasad PD, Wu X, et al. Cloning and functional
characterization of a potential-sensitive polyspecific organic
cation transporter (OCT3) most abundantly expressed in
placenta. J Biol Chem, 1998, 273:15971–15979.
Kerb R, Brinkmann U, Chatskaia N, et al. Identification of
genetic variations of the human organic cation transporter
hOCT1 and their functional consequences. Pharmacogenetics,
2002, 12:591–595.
Kidambi S, Patel S. Cholesterol and non-cholesterol sterol
transporters: ABCG5, ABCG8 and NPC1L1: A review.
Xenobiotica, 2008, 38:1119–1139.
Kikuchi R, Kusuhara H, Abe T, et al. Involvement of multiple
transporters in the efflux of 3-hydroxy-3-methylglutaryl-CoA
reductase inhibitors across the blood–brain barrier. J
Pharmacol Exp Ther, 2004, 311:1147–1153.
Kikuchi R, Kusuhara H, Hattori N, et al. Regulation of the
expression of human organic anion transporter 3 by hepatocyte
nuclear factor 1α/beta and DNA methylation. Mol Pharmacol,
2006, 70:887–896.
Kiser J, Aquilante C, Anderson P, et al. Clinical and genetic
determinants of intracellular tenofovir diphosphate
concentrations in HIV-infected patients. J Acquir Immune
Defic Syndr, 2008, 47:298–303.
Kitamura Y, Hirouchi M, Kusuhara H, et al. Increasing systemic
exposure of methotrexate by active efflux mediated by
multidrug resistance-associated protein 3 (MRP3/ABCC3). J
Pharmacol Exp Ther, 2008, 327:465–473.
Koepsell H. Organic cation transporters in intestine, kidney, liver,
and brain. Annu Rev Physiol, 1998, 60:243–266.
Koepsell H, Lips K, Volk C. Polyspecific organic cation transporters:
Structure, function, physiological roles, and biopharmaceutical
implications. Pharm Res, 2007, 24:1227–1251.
Konig J, Cui Y, Nies AT, Keppler D. Localization and genomic
organization of a new hepatocellular organic anion
transporting polypeptide. J Biol Chem, 2000, 275:23161–
23168.
Kopplow K, Letschert K, Konig J, et al. Human hepatobiliary
transport of organic anions analyzed by quadruple-transfected
cells. Mol Pharmacol, 2005, 68:1031–1038.
Krishnamurthy P, Schwab M, Takenaka K, et al. Transportermediated
protection against thiopurine-induced hematopoietic
toxicity. Cancer Res, 2008, 68:4983–4989.
Kullak-Ublick GA, Stieger B, Meier PJ. Enterohepatic bile salt
transporters in normal physiology and liver disease.
Gastroenterology, 2004, 126:322–342.
Kusuhara H, Sekine T, Utsunomiya-Tate N, et al. Molecular
cloning and characterization of a new multispecific organic
anion transporter from rat brain. J Biol Chem, 1999,
274:13675–13680.
Leabman MK, Huang CC, DeYoung J, et al. Natural variation in
human membrane transporter genes reveals evolutionary and
functional constraints. Proc Natl Acad Sci USA, 2003,
100:5896–5901.